Title:
テトラアザベンゾ[e]アズレン誘導体及びそれらのアナログ
Document Type and Number:
Japanese Patent JP4069159
Kind Code:
B2
Abstract:
This invention relates to CCK-A agonists of Formula (I) wherein R1-R4, A, B, X, D, E and G are as defined in the specification, as well as, among other things, pharmaceutical compositions containing the compounds and methods of use of the compounds and compositions. The compounds are useful in treating diabetes.
More Like This:
Inventors:
Cameron, Kimberly Okee
Elliott, Richard Lewis
Hammond, Marys
Elliott, Richard Lewis
Hammond, Marys
Application Number:
JP2007514174A
Publication Date:
April 02, 2008
Filing Date:
May 13, 2005
Export Citation:
Assignee:
Pfizer Products Inc.
International Classes:
C07D487/04; A61K31/551; C07D243/12; C07D243/24; C07D471/14; C07D487/14; C07D519/00
Domestic Patent References:
| JP9511999A | ||||
| JP50019773A | ||||
| JP50052093A |
Other References:
Ronald G. Sherrill et al.,Bioorganic & Medicinal Chemistry Letters,2001年,Vol.11, No.9,p.1145-1148
Attorney, Agent or Firm:
Yoshinobu Murofushi